Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7870925, 7 pages
http://dx.doi.org/10.1155/2016/7870925
Research Article

Serum Heme Oxygenase-1 and BMP-7 Are Potential Biomarkers for Bone Metabolism in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

1Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China
2Department of Health Statistics, West China School of Public Health, Sichuan University, Chengdu 610041, China
3Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
4Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan
5Institute of Integrative Medicine, China Medical University, Taichung 40201, Taiwan
6Department of Internal Medicine 3, University of Erlangen-Nuremberg, 91054 Erlangen, Germany

Received 12 April 2016; Revised 4 May 2016; Accepted 5 May 2016

Academic Editor: Hai-Feng Pan

Copyright © 2016 Tong-ling Yuan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Osta, F. Lavocat, A. Eljaafari, and P. Miossec, “Effects of interleukin-17A on osteogenic differentiation of isolated human mesenchymal stem cells,” Frontiers in Immunology, vol. 5, article 425, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Swales and A. Sabokbar, “Cellular and molecular mechanisms of bone damage and repair in inflammatory arthritis,” Drug Discovery Today, vol. 19, no. 8, pp. 1178–1185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Baum and E. M. Gravallese, “Bone as a target organ in rheumatic disease: impact on osteoclasts and osteoblasts,” Clinical Reviews in Allergy & Immunology, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Kitamura, K. Nishida, T. Komiyama et al., “Increased level of heme oxygenase-1 in rheumatoid arthritis synovial fluid,” Modern Rheumatology, vol. 21, no. 2, pp. 150–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. T. N. Crotti, A. A. S. S. K. Dharmapatni, E. Alias, and D. R. Haynes, “Osteoimmunology: major and costimulatory pathway expression associated with chronic inflammatory induced bone loss,” Journal of Immunology Research, vol. 2015, Article ID 281287, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kotake, Y. Nanke, T. Yago, M. Kawamoto, T. Kobashigawa, and H. Yamanaka, “Elevated ratio of Th17 cell-derived Th1 cells (CD161+Th1 Cells) to CD161+Th17 cells in peripheral blood of early-onset rheumatoid arthritis patients,” BioMed Research International, vol. 2016, Article ID 4186027, 5 pages, 2016. View at Publisher · View at Google Scholar
  7. M.-E. Truchetet, M. D. Mossalayi, and K. Boniface, “IL-17 in the rheumatologist's line of sight,” BioMed Research International, vol. 2013, Article ID 295132, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Baum and E. M. Gravallese, “Impact of inflammation on the osteoblast in rheumatic diseases,” Current Osteoporosis Reports, vol. 12, no. 1, pp. 9–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Clérigues, M. I. Guillén, M. A. Castejón, F. Gomar, V. Mirabet, and M. J. Alcaraz, “Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteoblasts,” Biochemical Pharmacology, vol. 83, no. 3, pp. 395–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Zwerina, S. Tzima, S. Hayer et al., “Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption,” The FASEB Journal, vol. 19, no. 14, pp. 2011–2013, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Devesa, M. L. Ferrándiz, M. C. Terencio, L. A. B. Joosten, W. B. Van Den Berg, and M. J. Alcaraz, “Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis,” Arthritis & Rheumatism, vol. 52, no. 10, pp. 3230–3238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. I. Guillén, J. Megías, F. Gomar, and M. J. Alcaraz, “Haem oxygenase-1 regulates catabolic and anabolic processes in osteoarthritic chondrocytes,” The Journal of Pathology, vol. 214, no. 4, pp. 515–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Clérigues, M. I. Guillén, F. Gomar, and M. J. Alcaraz, “Haem oxygenase-1 counteracts the effects of interleukin-1β on inflammatory and senescence markers in cartilage-subchondral bone explants from osteoarthritic patients,” Clinical Science, vol. 122, no. 5, pp. 239–251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-C. Park, Y.-B. Park, and S.-K. Lee, “Relationship of bone morphogenetic proteins to disease activity and radiographic damage in patients with ankylosing spondylitis,” Scandinavian Journal of Rheumatology, vol. 37, no. 3, pp. 200–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-A. Chen, C.-H. Chen, Y.-J. Lin et al., “Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis,” The Journal of Rheumatology, vol. 37, no. 10, pp. 2126–2132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Biver, P. Hardouin, and J. Caverzasio, “The ‘bone morphogenic proteins’ pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets,” Cytokine & Growth Factor Reviews, vol. 24, no. 1, pp. 69–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Komori, “Regulation of osteoblast differentiation by Runx2,” Advances in Experimental Medicine and Biology, vol. 658, pp. 43–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Braun and J. Sieper, “Ankylosing spondylitis,” The Lancet, vol. 369, no. 9570, pp. 1379–1390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Smith, “Update on ankylosing spondylitis: current concepts in pathogenesis,” Current Allergy and Asthma Reports, vol. 15, no. 1, article 489, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Kobayashi, M. Takeno, T. Saito et al., “Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 54, no. 4, pp. 1132–1142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Kirino, M. Takeno, S. Murakami et al., “Tumor necrosis factor α acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes,” Arthritis & Rheumatism, vol. 56, no. 2, pp. 464–475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Cao and D. Chen, “The BMP signaling and in vivo bone formation,” Gene, vol. 357, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. U. Lories, I. Derese, and F. P. Luyten, “Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis,” The Journal of Clinical Investigation, vol. 115, no. 6, pp. 1571–1579, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. E. D. Jensen, L. Pham, C. J. Billington Jr. et al., “Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors,” Journal of Cellular Biochemistry, vol. 109, no. 4, pp. 672–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Maurer, G. Zimmermann, S. Maurer, S. Stegmaier, C. Wagner, and G. M. Hänsch, “Inhibition of osteoclast generation: a novel function of the bone morphogenetic protein 7/osteogenic protein 1,” Mediators of Inflammation, vol. 2012, Article ID 171209, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Komori, “Regulation of skeletal development by the Runx family of transcription factors,” Journal of Cellular Biochemistry, vol. 95, no. 3, pp. 445–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Grcevic, Z. Jajic, N. Kovacic et al., “Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness,” The Journal of Rheumatology, vol. 37, no. 2, pp. 246–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Appel, L. Janssen, J. Listing, R. Heydrich, M. Rudwaleit, and J. Sieper, “Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment,” Arthritis Research & Therapy, vol. 10, no. 5, article R125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nagasue, M. Inaba, S. Okuno et al., “Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients,” Biomedicine & Pharmacotherapy, vol. 57, no. 2, pp. 98–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Neve, A. Corrado, and F. P. Cantatore, “Osteocalcin: skeletal and extra-skeletal effects,” Journal of Cellular Physiology, vol. 228, no. 6, pp. 1149–1153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Dong, G. Jiao, H. Liu et al., “Biological silicon stimulates collagen type 1 and osteocalcin synthesis in human osteoblast-like cells through the BMP-2/Smad/RUNX2 signaling pathway,” Biological Trace Element Research, 2016. View at Publisher · View at Google Scholar
  32. N. Makita, M. Suzuki, S. Asami et al., “Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells,” Gene, vol. 413, no. 1-2, pp. 8–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. A. J. Janckila, D. H. Neustadt, Y. R. Nakasato, J. M. Halleen, T. Hentunen, and L. T. Yam, “Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis,” Clinica Chimica Acta, vol. 320, no. 1-2, pp. 49–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Korkosz, J. Gasowski, P. Leszczyński et al., “Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity,” Scandinavian Journal of Rheumatology, vol. 43, no. 1, pp. 43–48, 2014. View at Publisher · View at Google Scholar · View at Scopus